Question to the Department of Health and Social Care:

To ask Her Majesty's Government what steps they are taking to ensure access to innovative medicines in order to improve the management of venous thromboembolism in the National Health Service.

The National Institute for Health and Care Excellence (NICE) has recommended a number of treatments for the prevention of venous thromboembolism. National Health Service commissioners are legally required by regulations to fund those treatments recommended by NICE in its technology appraisal guidance.

We understand that NHS England has established an Innovation Programme which ensures the commissioning system promotes and supports participation of the NHS in research, translating scientific developments into benefits for patients.